Alcohol-Related Disorders Completed Phase 1 / 2 Trials for Naltrexone (DB00704)

IndicationStatusPhase
DBCOND0027892 (Alcohol-Related Disorders)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02885311Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical HomeTreatment